Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw

J Rheumatol. 2009 Feb;36(2):451-3; author reply 453. doi: 10.3899/jrheum.080843.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Bone Density Conservation Agents / adverse effects
  • Canada / epidemiology
  • Causality
  • Diagnosis, Differential
  • Diphosphonates / adverse effects*
  • Humans
  • Incidence
  • Jaw Diseases / chemically induced*
  • Jaw Diseases / diagnosis
  • Jaw Diseases / prevention & control
  • Monitoring, Physiologic / standards
  • Osteonecrosis / chemically induced*
  • Osteonecrosis / diagnosis
  • Osteonecrosis / prevention & control
  • Osteoporosis / drug therapy
  • Periodontal Diseases / complications
  • Periodontal Diseases / prevention & control
  • Practice Guidelines as Topic*
  • Preventive Dentistry / standards
  • Risk Reduction Behavior

Substances

  • Bone Density Conservation Agents
  • Diphosphonates